Mupirocin, >=92% (HPLC), powder

Code: M7694-50MG D2-231

Not available outside of the UK & Ireland.

Application

Mupirocin has been used:for kinetic assayto assess its resistance by performing turbidity assayto determine its antimicrobial susceptibility

Biochem...


 Read more

Your Price
$605.79 50MG

Not available outside of the UK & Ireland.

Application

Mupirocin has been used:for kinetic assayto assess its resistance by performing turbidity assayto determine its antimicrobial susceptibility

Biochem/physiol Actions

Antibiotic; inhibits isoleucyl-tRNA synthetase (IRS).

Features and Benefits

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

General description

Mupirocin is produced by Pseudomonas fluorescens. It exhibits bacteriostatic action. Mupirocin is used to treat impetigo and skin infections.

Packaging

50, 100 mg in glass bottle

antibiotic activity spectrumfungi
assay≥92% (HPLC)
colorwhite to tan
formpowder
InChI keyMINDHVHHQZYEEK-HBBNESRFSA-N
InChI1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1
mode of actionprotein synthesis | interferes, enzyme | inhibits
optical activity[α]/D -15.7 to -20°, c = 1 in methanol
originatorGlaxoSmithKline
Quality Level100
SMILES string[H][C@@]1(CO[C@@H](CC(C)=CC(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O)C[C@@H]2O[C@@]2([H])[C@@H](C)[C@H](C)O
solubilityDMSO: ≥10 mg/mL
storage temp.room temp
Cas Number12650-69-0
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.